Italia markets closed

BMY Aug 2024 62.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
10,620,00 (0,00%)
Alla chiusura: 02:08PM EDT
Schermo intero
Chiusura precedente10,62
Aperto10,63
Denaro14,10
Lettera15,15
Prezzo d'esercizio62,50
Scadenza2024-08-16
Min-Max giorno10,60 - 10,63
Contratto - Min-MaxN/D
Volume4
Open Interest2
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri